Terms: = Breast cancer AND ZNF331, Q9NQX6, 55422, ENSG00000130844, ZNF361, RITA, ZNF463
23 results:
1. Decreased DNA Damage and Improved p53 Specificity of rita Analogs.
Zhan Y; Zhou X; Peuget S; Singh M; Peyser BD; Fan Z; Selivanova G
Mol Cancer Ther; 2022 Oct; 21(10):1524-1534. PubMed ID: 35877475
[TBL] [Abstract] [Full Text] [Related]
2. Mortality in patients with cancer and SARS-CoV-2 infection: Results from the Argentinean Network of Hospital-Based cancer Registries.
Fattore GL; Olivos NSA; Olalla JEC; Gomez L; Marucco AF; Mena MPR
Cancer Epidemiol; 2022 Aug; 79():102200. PubMed ID: 35772301
[TBL] [Abstract] [Full Text] [Related]
3. IMPLEMENTATION OF THE POLISH-UKRAINIAN PROJECT "SELF-DIAGNOSIS OF breast cancer IN YOUNG UKRAINIAN WOMEN" WITHIN THE FRAMEWORK OF THE rita PROGRAM - CHANGES IN THE REGION AT THE KHARKIV STATE ACADEMY OF PHYSICAL CULTURE.
Mulyk K; Skaliy A; Ruban L; Duhina L; Skaliy T; Nowikiewicz T; Kowalski W
Wiad Lek; 2022; 75(2):366-371. PubMed ID: 35307660
[TBL] [Abstract] [Full Text] [Related]
4. Identification and targeting of selective vulnerability rendered by tamoxifen resistance.
Singh M; Zhou X; Chen X; Santos GS; Peuget S; Cheng Q; Rihani A; Arnér ESJ; Hartman J; Selivanova G
Breast Cancer Res; 2020 Jul; 22(1):80. PubMed ID: 32727562
[TBL] [Abstract] [Full Text] [Related]
5. rita requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity.
Ristau J; van Hoef V; Peuget S; Zhu J; Guan BJ; Liang S; Hatzoglou M; Topisirovic I; Selivanova G; Larsson O
Cell Death Dis; 2019 Nov; 10(11):845. PubMed ID: 31699971
[TBL] [Abstract] [Full Text] [Related]
6. 20-Year Comparative Survival and Mortality of cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
7. Patients With breast cancer: Report From a National Hospital-Based cancer Registry in Argentina, 2012 to 2016.
Abriata MG; Macías GR
J Glob Oncol; 2019 Jan; 5():1-10. PubMed ID: 30657735
[TBL] [Abstract] [Full Text] [Related]
8. Role of p53 Gene in breast cancer: Focus on Mutation Spectrum and Therapeutic Strategies.
Kaur RP; Vasudeva K; Kumar R; Munshi A
Curr Pharm Des; 2018; 24(30):3566-3575. PubMed ID: 30255744
[TBL] [Abstract] [Full Text] [Related]
9. Wild-type p53 controls the level of fibronectin expression in breast cancer cells.
You D; Jung SP; Jeong Y; Bae SY; Kim S
Oncol Rep; 2017 Oct; 38(4):2551-2557. PubMed ID: 28765903
[TBL] [Abstract] [Full Text] [Related]
10. Quality of life of women with pre-and post-operative breast cancer.
Dell'Antônio Pereira L; Brandão-Souza C; Amaral Musso MA; Vieira Calmon M; Costa Neto SB; Monteiro de Barros Miotto MH; Zandonade E; Costa Amorim MH
Invest Educ Enferm; 2017 Jan; 35(1):109-119. PubMed ID: 29767930
[TBL] [Abstract] [Full Text] [Related]
11. Targeting NF-κB RelA/p65 phosphorylation overcomes rita resistance.
Bu Y; Cai G; Shen Y; Huang C; Zeng X; Cao Y; Cai C; Wang Y; Huang D; Liao DF; Cao D
Cancer Lett; 2016 Dec; 383(2):261-271. PubMed ID: 27721021
[TBL] [Abstract] [Full Text] [Related]
12. Allelic expression imbalance polymorphisms in susceptibility chromosome regions and the risk and survival of breast cancer.
Lin W; Lin HD; Guo XY; Lin Y; Su FX; Jia WH; Tang LY; Zheng W; Long JR; Ren ZF
Mol Carcinog; 2017 Jan; 56(1):300-311. PubMed ID: 27128794
[TBL] [Abstract] [Full Text] [Related]
13. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer.
Wang X; Docanto MM; Sasano H; ; Lo C; Simpson ER; Brown KA
Cancer Res; 2015 Feb; 75(4):645-55. PubMed ID: 25634217
[TBL] [Abstract] [Full Text] [Related]
14. Identifying breast cancer risk loci by global differential allele-specific expression (DASE) analysis in mammary epithelial transcriptome.
Gao C; Devarajan K; Zhou Y; Slater CM; Daly MB; Chen X
BMC Genomics; 2012 Oct; 13():570. PubMed ID: 23107584
[TBL] [Abstract] [Full Text] [Related]
15. Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis.
Nikulenkov F; Spinnler C; Li H; Tonelli C; Shi Y; Turunen M; Kivioja T; Ignatiev I; Kel A; Taipale J; Selivanova G
Cell Death Differ; 2012 Dec; 19(12):1992-2002. PubMed ID: 22790872
[TBL] [Abstract] [Full Text] [Related]
16. Image-based 3D modeling and validation of radiofrequency interstitial tumor ablation using a tissue-mimicking breast phantom.
Wang Z; Aarya I; Gueorguieva M; Liu D; Luo H; Manfredi L; Wang L; McLean D; Coleman S; Brown S; Cuschieri A
Int J Comput Assist Radiol Surg; 2012 Nov; 7(6):941-8. PubMed ID: 22688380
[TBL] [Abstract] [Full Text] [Related]
17. Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1.
Ahmed A; Yang J; Maya-Mendoza A; Jackson DA; Ashcroft M
Cell Death Dis; 2011 May; 2(5):e160. PubMed ID: 21593792
[TBL] [Abstract] [Full Text] [Related]
18. Neurotrophin in obstetrics and gynaecology.
Bose CK
J Stem Cells; 2009; 4(4):217-27. PubMed ID: 20720595
[TBL] [Abstract] [Full Text] [Related]
19. Helene Hudson Memorial Lectureship CANO 2008.
Benjaminson P
Can Oncol Nurs J; 2009; 19(2):65-71. PubMed ID: 19757764
[TBL] [Abstract] [Full Text] [Related]
20. Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: rita trial.
Loibl S; Murmann C; Schwedler K; Warm M; Müller L; Heinrich G; Nekljudova V; von Minckwitz G
Cancer Chemother Pharmacol; 2009 Apr; 63(5):953-8. PubMed ID: 18716777
[TBL] [Abstract] [Full Text] [Related]
[Next]
